496879-84-6 Usage
Uses
Used in Organic Synthesis:
5-(bromoacetyl)thiophene-2-carbonitrile is used as a synthetic intermediate for the preparation of various organic compounds. Its unique functional groups allow for versatile chemical reactions, facilitating the creation of a wide range of molecules with different properties and applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 5-(bromoacetyl)thiophene-2-carbonitrile is used as a key building block in the development of new drugs. Its structural features make it a promising candidate for the synthesis of bioactive molecules with potential therapeutic effects. Researchers may explore its use in the creation of compounds targeting specific diseases or conditions.
Used in Material Science:
5-(bromoacetyl)thiophene-2-carbonitrile may also find applications in material science, where its unique chemical structure could contribute to the development of new materials with specialized properties. These materials could be used in various high-tech applications, such as in electronics, sensors, or advanced coatings.
Used in Chemical Research:
As a compound with intriguing structural elements, 5-(bromoacetyl)thiophene-2-carbonitrile is used in academic and industrial research settings to study its chemical behavior, reactivity, and potential interactions with other molecules. This research can lead to a better understanding of its properties and uncover new ways to utilize it in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 496879-84-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,6,8,7 and 9 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 496879-84:
(8*4)+(7*9)+(6*6)+(5*8)+(4*7)+(3*9)+(2*8)+(1*4)=246
246 % 10 = 6
So 496879-84-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrNOS/c8-3-6(10)7-2-1-5(4-9)11-7/h1-2H,3H2
496879-84-6Relevant academic research and scientific papers
TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS
-
Paragraph 0255-0260, (2022/01/07)
The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
Novel Thienopyrimidones
-
Paragraph 0171; 0207-0212, (2021/04/17)
This invention relates to thienopyrimidinones and their use as inhibitors of TRPA1 activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of fibrotic diseases, inflammatory and auto-immune diseases and CNS-related diseases.
HETEROARYL-ETHANOLAMINE DERIVATIVES AS ANTIVIRAL AGENTS
-
Page 48-49, (2010/02/09)
The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Pyridoquinoxaline antivirals
-
, (2008/06/13)
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1, R2 and R3 are as defined in the specification. The compounds are useful for the treatment of viral infections.
